Alternative therapies for musculoskeletal conditions

Best Practice and Research: Clinical Rheumatology

Volumn 22, Issue 3, 2008, Pages 499-522

  Vitetta, Luis ^a   Cicuttini, Flavia ^b   Sali, Avni ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c National Institute of Integrative Medicine   (Australia)

Author keywords

botanicals; complementary and alternative medicine; mind body medicine; osteoarthritis; rheumatoid arthritis; supplements

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BOSWELLIA SERRATA EXTRACT; CATECHOL DERIVATIVE; CHONDROITIN SULFATE; CURCUMA LONGA EXTRACT; DIACETYLRHEIN; DICLOFENAC; GINGER EXTRACT; GLUCOSAMINE SULFATE; GREEN TEA EXTRACT; HARPOGOPHYTUM PROCUMBENS EXTRACT; HERBACEOUS AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PEPPER EXTRACT; PHENYLBUTAZONE; PLACEBO; PLANT EXTRACT; ROFECOXIB; S ADENOSYLMETHIONINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTERYGIUM WILFORDII EXTRACT; UNCARIA GUIANENSIS EXTRACT; UNCARIA TOMENTOSA EXTRACT; UNINDEXED DRUG; VALDECOXIB; WARFARIN; WILLOW EXTRACT;

ABDOMINAL PAIN; ACUPUNCTURE; ALTERNATIVE MEDICINE; AMENORRHEA; ANALGESIA; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CHRONIC DISEASE; CLINICAL TRIAL; DIARRHEA; DIET SUPPLEMENTATION; DIETARY INTAKE; DOSE RESPONSE; DROWSINESS; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ETHNICITY; EVIDENCE BASED MEDICINE; GASTROINTESTINAL IRRITATION; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HAIR LOSS; HARPOGOPHYTUM PROCUMBENS; HIP OSTEOARTHRITIS; HUMAN; HYPNOSIS; KNEE OSTEOARTHRITIS; LOW BACK PAIN; LOW DRUG DOSE; MEDICINAL PLANT; MEDITATION; MONOTHERAPY; MUSCULOSKELETAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RELAXATION TRAINING; REVIEW; RHEUMATOID ARTHRITIS; SKIN ALLERGY; SPOTTING; STRESS MANAGEMENT; SWELLING; SYMPTOM; TAI CHI; TREATMENT DURATION; UNCARIA; UNCARIA GUIANENSIS; UNCARIA TOMENTOSA; UNSPECIFIED SIDE EFFECT; URTICARIA; VOMITING; WILLOW; YOGA;

ACUPUNCTURE; ARTHRITIS, RHEUMATOID; DIETARY SUPPLEMENTS; HUMANS; OSTEOARTHRITIS; PHYTOTHERAPY;

EID: 44449116704     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2007.12.007     Document Type: Review

References (87)

1. Siebens H.C. Musculoskeletal problems as comorbidities. American Journal of Physical Medicine and Rehabilitation 86 (2007) S69-S78
2. Bergman S. Public health perspective-how to improve the musculoskeletal health of the population. Best Practice and Research. Clinical Rheumatology 21 (2007) 191-204
3. Centers for Disease Control and Prevention (CDC). Monitoring progress in arthritis management-United States and 25 states, 2003. MMWR Morbidity and Mortality Weekly Report 54 (2005) 484-488
4. Arden N., and Nevitt M.C. Osteoarthritis: epidemiology. Best Practice and Research. Clinical Rheumatology 20 (2006) 3-25
5. http://arthritisaustralia.com.au/media/file/Access%20Economics%20Report% 202001.pdf [accessed June 2007]
6. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. The Journal of American Medical Association 280 (1998) 1569-1575
7. MacLennan A.H., Myers S.P., and Taylor A.W. The continuing use of complementary and alternative medicine in South Australia costs and beliefs in 2004. Medical Journal of Australia 184 (2006) 27-31
8. Ernst E. Musculoskeletal conditions and complementary/alternative medicine. Best Practice and Research. Clinical Rheumatology 18 (2004) 539-556
9. Nagle D.G., Ferreira D., and Zhou Y.D. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry 67 (2006) 1849-1855
10. Hardin S.R. Cat's claw: an Amazonian vine decreases inflammation in osteoarthritis. Complementary Therapies in Clinical Practice 13 (2007) 25-28
11. Ahmed S., Anuntiyo J., Malemud C.J., et al. Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review. Evidence Based Complementary and Alternative Medicine 2 (2005) 301-308
12. Sharma R.A., Steward W.P., and Gescher A.J. Pharmacokinetics and pharmacodynamics of curcumin. Advances in Experimental Medicine and Biology 595 (2007) 453-470
13. Canter P.H., Lee H.S., and Ernst E. A systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis. Phytomedicine 13 (2006) 371-377
14. Curtis C.L., Harwood J.L., Dent C.M., et al. Biological basis for the benefit of nutraceutical supplementation in arthritis. Drug Discovery Today 9 (2004) 165-172
15. Mur E., Hartig F., Eibl G., et al. Randomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of Uncaria tomentosa for the treatment of rheumatoid arthritis. The Journal of Rheumatology 29 (2002) 656-658
16. Sandoval M., Okuhama N.N., Zhang X.J., et al. Anti-inflammatory and antioxidant activities of cat's claw (Uncaria tomentosa and Uncaria guianensis) are independent of their alkaloid content. Phytomedicine 9 (2002) 325-337
17. Chrubasik J.E., Roufogalis B.D., and Chrubasik S. Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytotheraphy Research 21 (2007) 675-683
18. Gagnier J.J., Chrubasik S., and Manheimer E. Harpgophytum procumbens for osteoarthritis and low back pain: a systematic review. BMC Complementary and Alternative Medicine 4 (2004) 13
19. Fiebich B.L., Heinrich M., Hiller K.O., et al. Inhibition of TNF-alpha synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69. Phytomedicie 8 (2001) 28-30
20. Huang T.H., Tran V.H., Duke R.K., et al. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappa B activation. Journal of Ethnopharmacology 104 (2006) 149-155
21. Chrubasik S., Conradt C., and Black A. The quality of clinical trials with Harpagophytum procumbens. Phytomedicine 10 (2003) 613-623
22. Chrubasik S., Model A., Black A., et al. A randomized double-blind pilot study comparing Doloteffin and Vioxx in the treatment of low back pain. Rheumatology 42 (2003) 141-148
23. Gagnier J.J., van Tulder M.W., Berman B., et al. Herbal medicine for low back pain: a Cochrane review. Spine 32 (2007) 82-92
24. Tao X., and Lipsky P.E. The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F. Rheumatic Diseases Clinics of North America 57 (2000) 1221-1227
25. Tao X., Younger J., Fan F.Z., et al. Benefit of an extract of Tripterygium wilfordii Hook F in patients with rheumatoid arthritis. Arthritis and Rheumatism 46 (2002) 1735-1743
26. Tao X., Cush J.J., Garret M., and Lipsky P.E. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. The Journal of Rheumatology 28 (2001) 2160-2167
27. Cibere J., Deng Z., Lin Y., et al. A randomized double blind, placebo controlled trial of topical Tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis. The Journal of Rheumatology 30 (2003) 465-467
28. Aggarwal B.B., and Shishodia S. Suppression of the nuclear factor-kB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Annals of the New York Academy of Sciences 1030 (2004) 434-441
29. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa). Journal of Alternative Complementary Medicine 9 (2003) 161-168
30. Joe B., Rao U.J., and Lokesh B.R. Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsaicin and curcumin. Molecular and Cellular Biochemistry 169 (1997) 125-134
31. Mukhopadhyay A., Basu N., Ghatak N., et al. Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents and Action 12 (1982) 508-515
32. Deodhar S.D., Sethi R., and Srimal R.C. Preliminary studies on antirheumatic activity of curcumin. The Indian Journal of Medicine Research 71 (1980) 632-634
33. Ippoushi K., Azuma K., Ito H., et al. [6]-Gingerol inhibits nitric oxide synthesis in activated J774.1 mouse macrophages and prevents peroxynitrite-induced oxidation and nitration reactions. Life Sciences 73 (2003) 3427-3437
34. Thomson M., Al-Qattan K.K., Al-Sawan S.M., et al. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins, Leukotrienes, and Essential Fatty Acids 67 (2002) 475-478
35. Jolad S.D., Lantz R.C., Solyom A.M., et al. Fresh organically grown ginger (Zingiber officinale): composition and effects on LPS-induced PGE2 production. Phytochemistry 65 (2004) 1937-1954
36. Altman R.D., and Marcussen K.C. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis and Rheumatism 44 (2001) 2531-2538
37. Bliddal H., Rosetzsky A., Schlichting P., et al. A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis Cartilage 8 (2000) 9-12
38. Srivastava K.C., and Mustafa T. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Medical Hypotheses 39 (1992) 342-348
39. Mason L., Moore R.A., Derry S., et al. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ (Clinical Research Ed.) 328 (2004) 991
40. Zhang B., Li J.B., Zhang D.M., et al. Analgesic and anti-inflammatory activities of a fraction rich in gaultherin isolated from Gaultheria yunnanensis. Biological and Pharmaceutical Bulletin 30 3 (2007) 465-469
41. Zhang B., He X.L., Ding Y., et al. Gaultherin, a natural salicylate derivative from Gaultheria yunnanensis: towards a better non-steroidal anti-inflammatory drug. European Journal of Pharmacology 530 1-2 (2006) 166-171
42. Chan T.Y. The risk of severe salicylate poisoning following the ingestion of topical medicaments or aspirin. Postgraduate Medical Journal 72 (1996) 109-112
43. Ernst E., and Chrubasik S. Phyto-anti-inflammatories. A systematic review of randomized, placebo-controlled, double-blind trials. Rheumatic Diseases Clinics of North America 26 (2000) 13-27
44. Ammon H.P. Boswellic acids in chronic inflammatory diseases. Planta Medica 72 (2006) 1100-1116
45. Gayathri B., Manjula N., Vinaykumar K.S., et al. Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNFalpha, IL-1beta, NO and MAP kinases. International Immunopharmacology 7 4 (2007) 473-482
46. Kimmatkar N., Thawani V., Hingorani L., et al. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee - a randomized double blind placebo controlled trial. Phytomedicine 10 (2003) 3-7
47. Sontakke S., Thawani S., Pimpalkhute P., et al. Open, randomized, controlled clinical trial of Boswellia serrata extract as compared to valdecoxib in osteoarthritis of knee. Indian Journal of Pharmacology 39 (2007) 27-29
48. Setty A.R., and Sigal L.H. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Seminars in Arthritis and Rheumatism 34 (2005) 773-784
49. Rossnagel K., Roll S., and Willich S.N. The clinical effectiveness of rosehip powder in patients with osteoarthritis. A systematic review. MMW Fortschritte der Medizin 149 (2007) 51-56
50. Chrubasik C., Duke R.K., and Chrubasik S. The evidence for clinical efficacy of rose hip and seed: a systematic review. Phytotheraphy Research 20 (2006) 1-3
51. Winther K., Apel K., and Thamsborg G. A powder made from seeds and shells of a rose-hip subspecies (Rosa canina)reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial. Scandinavian Journal of Rheumatology 34 (2005) 302-308
52. Wang Y., Prentice L.F., Vitetta L., et al. The effect of nutritional supplements on osteoarthritis. Alternative Medicine Review 9 (2004) 275-296
53. Vlad S.C., Lavalley M.P., McAlindon T.E., et al. Glucosamine for pain in osteoarthritis: Why do trial results differ?. Arthritis and Rheumatism 56 (2007) 2267-2277
54. Towheed T.E., Maxwell L., Anastassiades T.P., et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database of Systematic Reviews 2 (2005) CD002946
55. Poolsup N., Suthisisang C., Channark P., et al. Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials. Annals of Pharmacotherapy 39 (2005) 1080-1087
56. Towheed T.E., Anastassiades T.P., Shea B., et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database of Systematic Reviews 1 (2001) CD002946. Review
57. Distler J., and Anguelouch A. Evidence-based practice: review of clinical evidence on the efficacy of glucosamine and chondroitin in the treatment of osteoarthritis. Journal of the American Academy of Nurse Practitioners 18 (2006) 487-493
58. Reginster J.Y., Bruyere O., and Neuprez A. Current role of glucosamine in the treatment of osteoarthritis. Rheumatology 46 (2007) 731-735
59. Clegg D.O., Reda D.J., Harris C.L., et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. The New England Journal of Medicine 354 (2006) 795-808
60. Oliviero U., Sorrentino G.P., De Paola P., et al. Effects of the treatment with Matrix on elderly people with chronic articular degeneration. Drugs under Experimental and Clinical Research 17 (1991) 45-51
61. Conrozier T. Anti-arthrosis treatments: efficacy and tolerance of chondroitin sulfates (CS 4&6). La Presse Médicale 27 (1998) 1862-1865
62. Uebelhart D., Thonar E.J., Delmas P.D., et al. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage 6 (1998) 39-46
63. Bucsi L., and Poor G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 6 (1998) 31-36
64. Mazieres B., Combe B., Phan Van A., et al. Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study. The Journal of Rheumatology 28 (2001) 173-181
65. Morreale P., Manopulo R., Galati M., et al. Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. The Journal of Rheumatology 23 (1996) 1385-1391
66. Mathieu P. Radiological progression of internal femoro-tibial osteoarthritis in gonarthrosis. Chondro-protective effect of chondroitin sulfates ACS4-ACS6. Presse Medicale 31 (2002) 1386-1390
67. Pipitone V.R. Chondroprotection with chondroitin sulfate. Drugs under Experimental and Clinical Research 17 (1991) 3-7
68. Reichenbach S., Sterchi R., Scherer M., et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Annals of Internal Medicine 146 (2007) 580-590
69. Bello A.E., and Oesser S. Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature. Current Medical Research and Opinion 22 (2006) 2221-2232
70. Moskowitz R.W. Role of collagen hydrolysate in bone and joint disease. Seminars in Arthritis and Rheumatism 30 (2000) 87-99
71. Adam M. Therapy for osteoarthritis: which effects have preparations of gelatin?. Therapiewoche 38 (1991) 2456-2461
72. Usha P.R., and Naidu M.U.R. Randomised, double-blind, parallel, placebo- controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clinical Drug Investigation 24 (2004) 353-363
73. Kim L.S., Axelrod L.J., Howard P., et al. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage 14 (2006) 286-294
74. Soeken K., Lee W.L., Bausell R.B., et al. Safety and efficacy of S-adenosylmethionine (SAMe) for osteoarthritis. The Journal of Family Practice 5 (2002) 425-430
75. Tavoni A., Vitali C., Bombardieri S., et al. Evaluation of S-adenosylmethionine in primary fibromyalgia. A double-blind cross-over study. American Journal of Medicine 83 (1987) 107-110
76. Ameye L.G., and Chee W.S. Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Research Therapy 8 (2006) R127
77. Cobb C.S., and Ernst E. Systematic review of a marine nutriceutical supplement in clinical trials for arthritis: the effectiveness of the New Zealand green-lipped mussel Perna canaliculus. Clinical Rheumatology 25 (2006) 275-284
78. Blotman F., Maheu E., Wulwik A., et al. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial. Revue Du Rhumatisme (English Ed.) 64 (1997) 825-834
79. Appelboom T., Schuermans J., Verbruggen G., et al. Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. A double blind, prospective, placebo-controlled study. Scandinavian Journal of Rheumatology 30 (2001) 242-247
80. Maheu E., Mazieres B., Valat J.P., et al. Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect. Arthritis and Rheumatism 41 (1998) 81-91
81. Lequesne M., Maheu E., Cadet C., et al. Structural effect of avocado/soybean unsaponifiables on joint space loss in osteoarthritis of the hip. Arthritis and Rheumatism 47 (2002) 50-58
82. Ernst E. Avocado-soybean unsaponifiables (ASU) for osteoarthritis - a systematic review. Clinical Rheumatology 22 (2003) 285-288
83. Manheimer E., Linde K., Lao L., et al. Meta-analysis: acupuncture for osteoarthritis of the knee. Annals of Internal Medicine 146 (2007) 868-877
84. White A., Foster N.E., Cummings M., et al. Acupuncture treatment for chronic knee pain: a systematic review. Rheumatology 46 (2007) 384-390
85. Kwon Y.D., Pittler M.H., and Ernst E. Acupuncture for peripheral joint osteoarthritis: a systematic review and meta-analysis. Rheumatology 45 (2006) 1331-1337
86. Morone N.E., and Greco C.M. Mind-body interventions for chronic pain in older adults: a structured review. Pain Medicine 8 (2007) 359-375
87. Astin J.A. Mind-body therapies for the management of pain. The Clinical Journal of Pain 20 (2004) 27-32